UK health authorities pave the way for prescription-only stronger e-cigs

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is backing the idea of e-cigarettes as a licensed therapy, available on prescription from the National Health Service (NHS), for smokers who want to quit.

The MHRA’s updated “Guidance for licensing electronic cigarettes and other inhaled nicotine-containing products as medicines” suggests e-cigarettes may be made available for medicinal purposes in strengths and volumes greater than those currently permitted.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ UK health authorities pave the way for prescription-only stronger e-cigs ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ UK health authorities pave the way for prescription-only stronger e-cigs ”






      The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) is backing the idea of e-cigarettes as a licensed therapy, available on prescription from the National Health Service (NHS), for smokers who want to quit.

      The MHRA’s updated “Guidance for licensing electronic cigarettes and other inhaled nicotine-containing products as medicines” suggests e-cigarettes may be made available for medicinal purposes in strengths and volumes greater than those currently permitted.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik